Many terminal cancer patients put false hope in chemo, study finds

October 24, 2012 by Serena Gordon, Healthday Reporter
Many terminal cancer patients put false hope in chemo, study finds
Doctors must improve their message, researchers say.

(HealthDay)—Many people with incurable cancer mistakenly believe chemotherapy may save them, a new study finds.

Researchers at Dana-Farber Cancer Institute in Boston found that more than 80 percent of people with advanced colon cancer and nearly 70 percent with advanced thought chemo could cure their disease. In reality, chemo might give them several more months of life or ease troubling symptoms, but it rarely offers a cure for these diseases once they've spread to distant sites in the body.

"It's really easy for people to have expectations that aren't well aligned with reality," said the study's senior author, Dr. Deborah Schrag, an attending physician in adult oncology at Dana-Farber. "They want to be the one to beat the cancer. And, doctors want to be helpful. We want to be positive.

"What's clear," she added, "is that whatever we're doing right now, we need to change."

These misunderstandings may keep patients from making informed and preparing for death, say the study authors.

The study, published Oct. 25 in the , included almost 1,200 people who were part of the larger Outcomes Research and Surveillance study. The study volunteers were surveyed about four months after their diagnosis with advanced lung or colon cancer—cancer that had spread to other areas of their body (metastasized). Almost all were receiving chemotherapy.

Overall, 69 percent of the and 81 percent with colon cancer reported unrealistic expectations about the likelihood that their chemotherapy might cure them.

People with were more likely to believe that chemo might provide a cure, and blacks and Hispanics were significantly more likely to think that.

Patients who reported having favorable communication with their doctor were also more likely than others to expect a cure, the investigators found.

"You've been dealt a bad hand and, as your doctors, we want to help you cope," said Schrag. "But we may be robbing people of the opportunity to prioritize and make plans for what's important to them. We need to walk a fine line and have our patients hope for what's possible, but plan for what's probable."

Doctors also have to expect their popularity may drop in the face of truthful conversations, the study authors noted.

The co-author of an accompanying editorial, Dr. Thomas J. Smith, said what really matters is what people understand about their disease. "As long as these people are still planning for the worst, it's wonderful if they can be hoping for the best," he said.

Smith, director of palliative medicine at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, said that oncologists often need to change the way they deliver information to help people better understand what they can expect to happen.

"Oncologists like me are pretty good at saying to someone with lung cancer, 'This is something we can't cure.' But, that's very different than saying, 'What do you want to know about your disease?' or 'What do you understand about your disease?'" he said.

Smith said it's also important to have these types of discussions several times during the illness, and when someone has between three and six months left to live, it's important to discuss hospice care.

Misguided expectations also burden taxpayers. One-quarter of Medicare funds—the U.S. insurance program for the elderly—are spent in the year before death, in part because of late-stage chemotherapy, the editorialists noted.

"Chemotherapy can help ease symptoms, and some chemotherapy may extend life, but at some point chemotherapy can do you more harm than good," Smith said.

Schrage added, "It's important to know that is helpful and valuable. It's not worthless by any means. But, hopefully patients will feel empowered to ask, 'How will this help me?' and 'What is realistic for me to expect?'"

She said it's also very helpful to bring someone to your doctor's appointment, because it's often hard to focus on what the doctor is saying after you've been given difficult, life-altering news.

Explore further: Avastin no benefit to older lung cancer patients: study

More information: There's more on chemotherapy at the American Cancer Society.

Related Stories

Avastin no benefit to older lung cancer patients: study

April 17, 2012
(HealthDay) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer Institute report.

Pre-op treatments boost survival for esophageal cancer patients: study

May 30, 2012
(HealthDay) -- Patients with esophageal cancer who receive chemotherapy and radiation before surgery have better outcomes, Dutch researchers report.

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

September 30, 2012
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 ...

Certain head and neck cancer patients benefit from second round of treatment

June 13, 2011
A new study has determined predictors that can better identify patients who will benefit from a potentially toxic second course of treatment, which offers a small but real chance of cure in select patients with head and neck ...

High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy

July 5, 2011
High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

gwrede
1 / 5 (1) Oct 25, 2012
"It's really easy for people to have expectations that aren't well aligned with reality," said the study's senior author, Dr. Deborah Schrag.

Overall, 69 percent of the lung cancer patients and 81 percent with colon cancer reported unrealistic expectations about the likelihood that their chemotherapy might cure them.
I think Dr. Schrag will have a somewhat other opinion the day she's got colon cancer. But for now, while she still is blissfully naive about how it really feels, we have to be patient with her.

Of course it would be easier on us if these cancer patients would go home and start planning their funeral and the color of their coffin. They could also alleviate many survivors lives by settling their disputes with everybody, so that the living don't have to feel bad once they've died.

Let's wait and see what she does when it's her turn.
freethinking
3 / 5 (2) Oct 25, 2012
gwrede, I like your comment let's wait and see what she does when it's her turn.

I think we can both agree that if a patient wants chemo then it should be done.

Personally (yes at this time I don't have cancer that I know of), if given the option of taking chemo to extend my life a few months, I think I would skip it. That is IF it doesn't reduce pain. I'm also in favor of giving a terminal person as much pain killers as they need or want, but thats another story.

Again, this is just me, and as I've said I'm all in favor of patients right to choose what they think is best for them. Death comes to us all, so fighting it for a few extra months in pain I don't think is worth it.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.